Magnetic Resonance Imaging and Clinical Features of the Demyelinating Degeneration of White Matter in Young Patients

References

• Barbosa BC, Marchiori E, Leal Leidersnaider C, Brandao L, Castillo M. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques. Neuroradiol J. 2019;32(2):103–107. doi:10.1177/1971400919826394
   PubMed Web of Science ®Google Scholar
• Giorgio A, De Stefano N. Effective utilization of MRI in the diagnosis and management of multiple sclerosis. Neurol Clin. 2018;36(1):27–34. doi:10.1016/j.ncl.2017.08.013
   PubMed Web of Science ®Google Scholar
• Balashov K. Imaging of central nervous system demyelinating disorders. Continuum. 2016;22(5):1613–1635. doi:10.1212/CON.0000000000000373
   PubMedGoogle Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revision of the McDonald criteria. Lancet Neurol. 2017;17(2):162–173. doi:10.1016/S1474-4422(17)30470-2
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al.; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Neuroradiol. 1987;149(2):421–426.
   Google Scholar
• Senda J, Ito K, Kotake T, et al. Association of leukoaraiosis with convalescent rehabilitation outcome in patients with ischemic stroke. Stroke. 2016;47(1):160–166. doi:10.1161/STROKEAHA.115.010682
   PubMed Web of Science ®Google Scholar
• Mathey G, Michaud M, Pittion-Vouyovitch S, Debouverie M. Classification and diagnostic criteria for demyelinating diseases of the central nervous system: where do we stand today? Rev Neurol. 2018;174(6):378–390. doi:10.1016/j.neurol.2018.01.368
   PubMed Web of Science ®Google Scholar
• Höftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system. Handb Clin Neurol. 2017;145:263–283.
   PubMedGoogle Scholar
• Zéphir H. Progress in understanding the pathophysiology of multiple sclerosis. Rev Neurol. 2018;174(6):358–363. doi:10.1016/j.neurol.2018.03.006
   PubMed Web of Science ®Google Scholar
• Matute-Blanch C, Montalban X, Comabella M. Multiple sclerosis, and ther demyelinating and autoimmune inflammatory diseases of the central nervous system. Handb Clin Neurol. 2017;146:67–84.
   PubMedGoogle Scholar
• Buzzard K, Chan WH, Kilpatrick T, Murray S. Multiple sclerosis: basic and clinical. Adv Neurobiol. 2017;15:211–252.
   PubMedGoogle Scholar
• Duncan ID, Radcliff AB. Inherited and acquired disorders of myelin: the underlying myelin pathology. Exp Neurol. 2016;283(Pt B):452–475.
   PubMed Web of Science ®Google Scholar
• Filippi M, Preziosa P, Rocca MA. MRI in multiple sclerosis: what is changing? Curr Opin Neurol. 2018;31(4):386–395. doi:10.1097/WCO.0000000000000572
   PubMed Web of Science ®Google Scholar
• Wijnands JMA, Kingwell E, Zhu F, et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. Lancet Neurol. 2017;16(6):445–451. doi:10.1016/S1474-4422(17)30076-5
   PubMed Web of Science ®Google Scholar
• Chau V, Synnes A, Grunau RE, Poskitt KJ, Brant R, Miller SP. Abnormal brain maturation in preterm neonates associated with adverse developmental outcome. Neurology. 2013;81(24):2082–2089. doi:10.1212/01.wnl.0000437298.43688.b9
   PubMed Web of Science ®Google Scholar
• Lundgren C, Brudin L, Wanby AS, Blomberg M. Ante- and intrapartum risk factors for neonatal hypoxic ischemic encephalopathy. J Matern Fetal Neonatal Med. 2018;31(12):1595–1601. doi:10.1080/14767058.2017.1321628
   PubMed Web of Science ®Google Scholar
• Jonsson M, Zetterberg H, van Straaten E, et al. Cerebrospinal fluid biomarkers of white matter lesions-cross-sectional results from the LADIS study. Eur J Neurol. 2010;17:377–382. doi:10.1111/j.1468-1331.2009.02808.x
   PubMed Web of Science ®Google Scholar
• Li YH, Yang Y, Reis C, et al. Cerebral small vessel disease. Cell Transplant. 2018;27:1711–1722. doi:10.1177/0963689718795148
   PubMed Web of Science ®Google Scholar
• Haider L, Zrzavy T, Hametner S, et al. The topography of demyelination and neurodegeneration in the multiple sclerosis brain. Brain. 2016;139(3):807–815. doi:10.1093/brain/awv398
   PubMed Web of Science ®Google Scholar
• Desai RA, Davies AL, Tachrount M, et al. Cause and prevention of demyelination in a model multiple sclerosis lesion. Ann Neurol. 2016;79(4):591–604. doi:10.1002/ana.24607
   PubMed Web of Science ®Google Scholar
• Davies AL, Desai RA, Bloomfield PS, et al. Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol. 2013;74(6):815–825. doi:10.1002/ana.24006
   PubMed Web of Science ®Google Scholar
• Nikic I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011;17:495–499. doi:10.1038/nm.2324
   PubMed Web of Science ®Google Scholar
• Szolnoki Z, Szekeres M, Szaniszlo I, et al. Decreased number of mitochondria in leukoaraiosis. Arch Med. 2015;46(8):604–608.
   Google Scholar
• Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. 2011;12:723–739.
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–285. doi:10.1056/NEJM199801293380502
   PubMed Web of Science ®Google Scholar
• Rizvi B, Narkhede A, Last BS, et al. The effect of with matter hyperintensities on cognition is mediated by cortical atrophy. Neurobio Aging. 2018;64:25–32. doi:10.1016/j.neurobiolaging.2017.12.006
   PubMed Web of Science ®Google Scholar